Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Sabrient QES Index Series
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
»
Feed aggregator
»
Sources
https://seekingalpha.com
URL:
https://seekingalpha.com
Updated:
1 hour 4 min ago
JBS: Attractive Risk/Reward Opportunity
Fri, 03/27/2026 - 07:00
Harry Qelm Baabsman's 2025 FY Letter To Investors
Fri, 03/27/2026 - 07:00
Top Low-Beta Dividend Stocks For Volatile Markets
Fri, 03/27/2026 - 07:00
JIRE: A Decent Core ETF, But No Proven Edge Over Its Benchmark
Fri, 03/27/2026 - 07:00
Canadian National Railway: Don't Play On Railroad Tracks, Own Them
Fri, 03/27/2026 - 07:00
Disney: Parks Is The Company's Core Now, But The Core Of Parks Isn't Talked About At All
Fri, 03/27/2026 - 07:00
Seeing Past The Market Turmoil To Find Alpha
Fri, 03/27/2026 - 07:00
Conagra Brands: I'm Bullish Despite Modest Expectations For Q3 Earnings
Fri, 03/27/2026 - 07:00
The Strait Of Hormuz Toll Is Not Financially Viable (Here's Why)
Fri, 03/27/2026 - 06:58
IREN Is Racing To Win AI's Most Constrained Resource - And It's Already Winning
Fri, 03/27/2026 - 06:58
4 stocks to watch on Friday: MU, TGT, AAPL, META
Fri, 03/27/2026 - 06:57
Two Harbors terminates UWM deal for CrossCountry's superior $10.80 per share offer
Fri, 03/27/2026 - 06:52
The End Of Bitcoin Will Be Its New Beginning
Fri, 03/27/2026 - 06:52
Bessent denies FT report on BoE-style Fed oversight
Fri, 03/27/2026 - 06:50
Length of Iran war in focus as Nasdaq falls into correction territory
Fri, 03/27/2026 - 06:49
Alight receives NYSE noncompliance notice
Fri, 03/27/2026 - 06:47
Graphite Miners News For The Month Of March 2026
Fri, 03/27/2026 - 06:46
Navan Q4 Review: Relief Rally Creates Exit Opportunity
Fri, 03/27/2026 - 06:45
Glow Lifetech reduces over 41M warrants, 5M options
Fri, 03/27/2026 - 06:43
AstraZeneca succeeds in two Phase 3 trials for COPD therapy
Fri, 03/27/2026 - 06:39
Pages
« first
‹ previous
…
1894
1895
1896
1897
1898
1899
1900
1901
1902
…
next ›
last »